Trigonostemon reidioides modulates endothelial cell proliferation, migration and tube formation via downregulation of the Akt signaling pathway

Cho,Young‑Rak; Park,Kyuhee; Kang,Jae‑Shin; Byun,Hye‑Woo; Oh,Joa  Sub; Seo,Dong‑Wan; Ahn,Eun‑Kyung

doi:10.3892/ol.2017.6760

Trigonostemon reidioides modulates endothelial cell proliferation, migration and tube formation via downregulation of the Akt signaling pathway

Authors:
- Young‑Rak Cho
- Kyuhee Park
- Jae‑Shin Kang
- Hye‑Woo Byun
- Joa Sub Oh
- Dong‑Wan Seo
- Eun‑Kyung Ahn
View Affiliations

Affiliations: Bio‑Center, Gyeonggi Institute of Science and Technology Promotion, Suwon, Gyeonggi 16229, Republic of Korea, Biological Genetic Resources Utilization Division, National Institute of Biological Resources, Seo, Incheon 22689, Republic of Korea, Department of Pharmacy, College of Pharmacy, Dankook University, Cheonan, Chungcheong 31116, Republic of Korea
Published online on: August 17, 2017 https://doi.org/10.3892/ol.2017.6760
Pages: 4677-4683
Copyright: © Cho et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Trigonostemon reidi`oides (TR) is used as a Thai traditional medicine for the treatment of drug addiction, asthma, food poisoning, constipation and snake bites. The present study investigated the effects and molecular mechanisms of the ethanolic extract of TR (ETR) on mitogen‑induced human umbilical vein endothelial cells (HUVECs) responses, proliferation, adhesion, migration and tube formation. ETR treatment inhibited mitogen‑induced HUVEC proliferation by downregulation of cell cycle‑associated proteins, including cyclins and cyclin‑dependent kinases, which induced retinoblastoma protein hypophosphorylation. The present study also demonstrated that ETR treatment suppressed mitogen‑induced HUVEC adhesion, migration, invasion and tube formation, and that these anti‑angiogenic activities were mediated by inactivation of mitogen‑induced Akt and matrix metalloproteinase (MMP)‑2, but not of extracellular signal‑regulated kinase, p70 ribosomal S6 kinase or MMP‑9. Collectively, the results of the present study suggested pharmacological functions and molecular mechanisms of ETR in regulating endothelial cell fates, and supported further evaluation and development of ETR as a potential therapeutic agent for the treatment and prevention of angiogenesis‑associated diseases, including cancer.

View Figures

View References

1	Cristofanilli M, Charnsangavej C and Hortobagyi GN: Angiogenesis modulation in cancer research: Novel clinical approaches. Nat Rev Drug Discov. 1:415–426. 2002. View Article : Google Scholar : PubMed/NCBI
2	Folkman J: Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007. View Article : Google Scholar : PubMed/NCBI
3	Carmeliet P and Jain RK: Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 10:417–427. 2011. View Article : Google Scholar : PubMed/NCBI
4	Cook KM and Figg WD: Angiogenesis inhibitors: Current strategies and future prospects. CA Cancer J Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
5	Jain RK, Duda DG, Clark JW and Loeffler JS: Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Prac Oncol. 3:24–40. 2006. View Article : Google Scholar
6	Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR and Adamis AP: Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov. 5:123–132. 2006. View Article : Google Scholar : PubMed/NCBI
7	Brown DM and Regillo CD: Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 144:627–637. 2007. View Article : Google Scholar : PubMed/NCBI
8	Ellis LM and Hicklin DJ: VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer. 8:579–591. 2008. View Article : Google Scholar : PubMed/NCBI
9	Coffer PJ, Jin J and Woodgett JR: Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J. 335:1–13. 1998. View Article : Google Scholar : PubMed/NCBI
10	Kandel ES and Hay N: The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res. 253:210–229. 1999. View Article : Google Scholar : PubMed/NCBI
11	Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, et al: Akt1/protein kinase B is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest. 115:2119–2127. 2005. View Article : Google Scholar : PubMed/NCBI
12	Yang XM, Wang YS, Zhang J, Li Y, Xu JF, Zhu J, Zhao W, Chu DK and Wiedemann P: Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci. 50:1873–1879. 2009. View Article : Google Scholar : PubMed/NCBI
13	You JJ, Yang CH, Yang CM and Chen MS: Cyr61 induces the expression of monocyte chemoattractant protein-1 via the integrin ανβ3, FAK, PI3K/Akt and NF-κB pathways in retinal vascular endothelial cells. Cell Signal. 26:133–140. 2014. View Article : Google Scholar : PubMed/NCBI
14	Di Y, Zhang Y, Nie Q and Chen X: CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy. Int J Mol Med. 36:1507–1518. 2015. View Article : Google Scholar : PubMed/NCBI
15	Clark AS, West K, Streicher S and Dennis PA: Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther. 1:707–717. 2002.PubMed/NCBI
16	Knuefermann C, Lu Y, Liu B, Jin W, Liang K, Wu L, Schmidt M, Mills GB, Mendelsohn J and Fan Z: HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene. 22:3205–3212. 2003. View Article : Google Scholar : PubMed/NCBI
17	Katso R, Okkenhaug K, Ahmadi K, White S, Timms J and Waterfield MD: Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 17:615–675. 2001. View Article : Google Scholar : PubMed/NCBI
18	Tempeam A, Thasana N, Pavaro C, Chuakul W, Siripong P and Ruchirawat S: A new cytotoxic daphnane diterpenoid, rediocide G, from Trigonostemon reidioides. Chem Pharm Bull (Tokyo). 53:1321–1323. 2005. View Article : Google Scholar : PubMed/NCBI
19	Biodiversity of Cambodia, Cardamom protected forest and Seima biodiversity conservation area. NIBR. 1642012.
20	Chuakul W, Saralump P and Prathanturarug S: Medicinal Plants in Thailand. 2. Amarin Printing and Publishing Public Co., Ltd.; Bangkok: 1997
21	Tempeam A, Thasana N, Thavornkitcharat A, Pavaro C and Ruchirawat S: In vitro cytotoxicity of some Thai medicinal plants and daphnane diterpenoid from Trigonostemon redioides. Mahidol U J Pharm Sci. 29:25–31. 2002.
22	Seo DW, Kim SH, Eom SH, Yoon HJ, Cho YR, Kim PH, Kim YK, Han JW, Diaz T, Wei BY and Stetler-Stevenson WG: TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvasc Res. 76:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
23	Seo DW, Li H, Qu CK, Oh J, Kim YS, Diaz T, Wei B, Han JW and Stetler-Stevenson WG: Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem. 281:3711–3721. 2006. View Article : Google Scholar : PubMed/NCBI
24	Cho YR, Kim SH, Ko HY, Kim MD, Choi SW and Seo DW: Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70S6K-dependent VEGFR-2 expression. Oncol Rep. 26:861–867. 2011.PubMed/NCBI
25	Cho YR, Choi SW and Seo DW: The in vitro antitumor activity of Siegesbeckia glabrescens against ovarian cancer through suppression of receptor tyrosine kinase expression and the signaling pathways. Oncol Rep. 30:221–226. 2013. View Article : Google Scholar : PubMed/NCBI
26	Lee HN, Joo JH, Oh JS, Choi SW and Seo DW: Regulatory effects of Siegesbeckia glabrescens on non-small cell lung cancer cell proliferation and invasion. Am J Chin Med. 42:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
27	Harbour JW, Luo RX, Santi AD, Postigo AA and Dean DC: Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:859–869. 1999. View Article : Google Scholar : PubMed/NCBI
28	Lemmon MA and Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010. View Article : Google Scholar : PubMed/NCBI
29	Kokpol U, Thebpatiphat S, Boonyaratavej S, Chedchuskulcai V, Ni CZ, Clardy J, Chaichantipyuth C, Chittawong V and Miles DH: Structure of trigonostemone, a new phenanthrenone from the Thai plant Trigonostemon reidioides. J Nat Prod. 53:1148–1151. 1990. View Article : Google Scholar
30	Kanchanapoom T, Kasai R, Chumsri P, Kraisintu K and Yamasaki K: Lotthanongine, an unprecedented flavonoidal indole alkaloid from the roots of Thai medicinal plant, Trigonostemon reidioides. Tetrahedron Lett. 43:2941–2943. 2002. View Article : Google Scholar
31	Jayasuriya H, Zink DL, Singh SB, Borris RP, Nanakorn W, Beck HT, Balick MJ, Goetz MA, Slayton L, Gregory L, et al: Structure and stereochemistry of rediocide A, a highly modified daphnane from Trigonostemon reidioides exhibiting potent insecticidal activity. J Am Chem Soc. 122:4998–4999. 2000. View Article : Google Scholar
32	Jayasuriya H, Zink DL, Borris RP, Nanakorn W, Beck HT, Balick MJ, Goetz MA, Gregory L, Shoop WL and Singh SB: Rediocides B-E, potent insecticides from Trigonostemon reidioides. J Nat Prod. 67:228–231. 2004. View Article : Google Scholar : PubMed/NCBI
33	Soonthornchareonnon N, Sakayarojkul M, Isaka M, Mahakittikun V, Chuakul W and Wongsinkongman P: Acaricidal daphnane diterpenoids from Trigonostemon reidioides (KURZ) CRAIB roots. Chem Pharm Bull (Tokyo). 53:241–243. 2005. View Article : Google Scholar : PubMed/NCBI
34	He W, Cik M, Appendino G, Puyvelde LV, Leysen JE and De Kimpe N: Daphnane-type diterpene orthoesters and their biological activities. Mini Rev Med Chem. 2:185–200. 2002. View Article : Google Scholar : PubMed/NCBI
35	Pettit GR, Ducki S, Tan R, Gardella RS, McMahon JB, Boyd MR, Pettit GR III, Blumberg PM, Lewin NE, Doubek DL, et al: Isolation and structure of pedilstatin from a republic of maldives Pedilanthus sp. J Nat Prod. 65:1262–1265. 2002. View Article : Google Scholar : PubMed/NCBI
36	Chumkaew P, Karalai C, Ponglimanont C and Chantrapromma K: Antimycobacterial activity of phorbol esters from the fruits of Sapium indicum. J Nat Prod. 66:540–543. 2003. View Article : Google Scholar : PubMed/NCBI
37	Kim JH, Kim HJ, Kim JK, Ahn EK, Ko HJ, Cho YR, Lee SJ, Bae GU, Kim YK, Park JW, et al: Ligularia fischeri inhibits endothelial cell proliferation, invasion and tube formation through the inactivation of mitogenic signaling pathways and regulation of vascular endothelial cadherin distribution and matrix metalloproteinase expression. Oncol Rep. 34:221–226. 2015. View Article : Google Scholar : PubMed/NCBI
38	Cho YR, Kim JH, Kim JK, Ahn EK, Ko HJ, In JK, Lee SJ, Bae GU, Kim YK, Oh JS, et al: Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70S6K-dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation. Oncol Rep. 32:1531–1536. 2014. View Article : Google Scholar : PubMed/NCBI